Lorne Tyrrell
Affiliations: | University of Alberta, Edmonton, Alberta, Canada |
Area:
Immunology, Microbiology BiologyGoogle:
"Lorne Tyrrell"Children
Sign in to add trainee| Woei G. Tan | grad student | 2000 | University of Alberta |
| Kathie-Anne Walters | grad student | 2003 | University of Alberta |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Zietara F, Crotty P, Houghton M, et al. (2020) Sociodemographic risk factors for hepatitis C virus infection in a prospective cohort study of 257 persons in Canada who inject drugs. Canadian Liver Journal. 3: 276-285 |
| Yakovenko I, Hyshka E, Tyrrell L, et al. (2019) Willingness to participate in hepatitis C vaccine trials among socially marginalized people who use drugs. Journal of Substance Abuse Treatment. 101: 67-71 |
| Okoye IS, Houghton M, Tyrrell L, et al. (2017) Coinhibitory Receptor Expression and Immune Checkpoint Blockade: Maintaining a Balance in CD8(+) T Cell Responses to Chronic Viral Infections and Cancer. Frontiers in Immunology. 8: 1215 |
| Ahmed M, Wang F, Levin A, et al. (2015) Targeting the Achilles heel of the hepatitis B virus: a review of current treatments against covalently closed circular DNA. Drug Discovery Today. 20: 548-61 |
| Yi M, Hu F, Joyce M, et al. (2014) Evolution of a cell culture-derived genotype 1a hepatitis C virus (H77S.2) during persistent infection with chronic hepatitis in a chimpanzee. Journal of Virology. 88: 3678-94 |
| Kneteman NM, Asthana S, Lewis J, et al. (2012) Impact of calcineurin inhibitors with or without interferon on hepatitis C virus titers in a chimeric mouse model of hepatitis C virus infection. Liver Transplantation : Official Publication of the American Association For the Study of Liver Diseases and the International Liver Transplantation Society. 18: 38-44 |
| Walters KA, Tipples GA, Allen MI, et al. (2003) Generation of stable cell lines expressing Lamivudine-resistant hepatitis B virus for antiviral-compound screening. Antimicrobial Agents and Chemotherapy. 47: 1936-42 |
| Hsi B, Schiller D, Fischer K, et al. (2003) 251 Establishing the validity of the ALB-UPA/SCID mouse model of HCV in the testing of anti-viral therapies Hepatology. 38: 278-278 |
| Hsi B, Hsu E, Richardson C, et al. (2003) 61 Inducing apoptosis in hepatitis C infected Alb-UPA/SCID mice with gene therapy mechanisms Hepatology. 38: 184-184 |